Gilad&Gilad LLC, the exclusive supplier of Neurofencine(TM), has recently begun distributions in Singapore. The collaborating distributor in Singapore is marketing Neurofencine(TM) to healthcare professionals, pharmacies and health stores.
Neurofencine(TM) is a novel, first-of-its-kind neuroprotective supplement containing G-agmatine®, Gilad&Gilad's exclusive brand of the amino acid metabolite agmatine. Recent clinical studies demonstrated the safety profile of G-agmatine® and the efficacy of this novel nutraceutical in alleviating neuropathic pain and improving quality of life in people suffering from sciatica. These studies together with ample scientific evidence, support marketing claims of Neurofencine(TM) for "pain-free nerve functions", for "spine-nerve structure/function benefits" and for "better quality of life".
Neurofencine(TM) is manufactured in the USA under the highest quality standards and regulations and is available only from Gilad&Gilad. It is presently, being sold direct to consumers online, to practicing healthcare professionals, to health stores and to regional distributors.
"With its network of affiliates, our Singaporean partner is expected to give our company a foothold in other countries in South East Asia including: Malaysia and Indonesia, thus opening for us the gate to the large market of this region of the world", says Dr. Gad Gilad, CEO of Gilad&Gilad.
More than 20 million people in the United States alone cope with circumstances that affect healthy nerve functions without a satisfactory solution. Neurofencine(TM) is poised to improve the quality of life of multitude of people worldwide whose need for healthier pain-free nerve functions remained unmet until now.
About Gilad&Gilad LLC
Gilad&Gilad is a privately owned USA company in Reseda, California, with a mission to provide evidence-based safe and effective products of superior quality for healthier nervous system functions and a better quality of life. It was founded in 2009 by Dr. Gad Gilad and Varda Gilad following years of collaborative scientific research and based on their breakthrough discovery of the neuroprotective properties of G-agmatine®. The Company builds its reputation on continuous investment in sound scientific and clinical research, thus earning the trust of healthcare professionals and gaining credibility with the public. For further information about Gilad&Gilad please visit the website: www.ForNerveHealth.com